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ABSTRACT
Introduction: This study was conducted to
investigate the fear of self-injecting and
self-testing and its related risk factors among
adolescents with type 1 diabetes mellitus
(T1DM).
Methods: From December 2015 to April 2016, a
cross-sectional study was performed at the
Diabetes Treatment Center, Prince Sultan
Military Medical City, Riyadh, Saudi Arabia on
142 registered T1DM patients between 13 and
19 years of age. Selection of the respondents was
done deliberately and carefully, and the
suitable patients were given specific
identification numbers. A trained interviewer
administered the short Diabetes Fear of
Injecting and Self-testing Questionnaire to
each patient. It included two subscales
estimating the fear of self-injection (FSI) and
fear of self-testing (FST). Each patient’s age,
gender, weight, height, adjusted body mass
index (BMI), duration of the diabetic
condition, treatment modality, insulin dosage,
and glycosylated hemoglobin (HbA1c) were
recorded.
Results: The study found that the overall mean
score of FSI was 2.44 ± 0.96, whereas that of FST
was 2.25 ± 1.04. Adolescents above 16 years of
age, treated with multiple daily insulin (MDI),
on higher insulin doses, having poor glycemic
control, and fewer finger pricks were observed
to show significant risk factors for fear of
self-injection of insulin, whereas in those
patients having a long duration of T1DM, MDI
treated, on higher insulin doses, with poor
glycemic control, and fewer finger pricks
showed significant risk factors for fear of
self-testing of blood glucose. From the
regression analysis it was evident that the
variables of higher age, MDI treatment, and
fewer finger pricks were independent risk factors
for fear of self-injection of the insulin, whereas a
fewer number of finger pricks was an
independent risk factor for fear of self-testing
the blood glucose.
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Conclusion: Fear of self-injecting and fear of
self-testing are common among adolescents
with T1DM. Therefore, it is essential to ensure
comprehensive multidisciplinary diabetes
education to lower the risk factor of fear of
injections.
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INTRODUCTION
The World Health Organization (WHO) has
stated that Saudi Arabia ranks the second
highest in the Middle East, and is seventh in
the world for the rate of diabetes. Type 2
diabetes mellitus (T2DM) predominates, while
type 1 diabetes mellitus (T1DM) continues to
pose a significant public health problem in
Saudi Arabia [1]. Over the past three decades,
the incidence and prevalence of T1DM have
been increasing in Saudi Arabia and currently
the prevalence of T1DM in Saudi Arabian
children and adolescents is 109.5 per 100,000
people [1].
For adolescent T1DM patients, disease
management includes frequent blood sugar
monitoring and multiple daily injections
(MDI) of insulin necessitating a minimum of
four injections each day or a continuous
subcutaneous insulin infusion (CSII) via an
insulin pump which needs the infusion site to
be changed every 2 to 3 days [2]. For both the
newly diagnosed patient and the long-term
ones, the process of injecting and blood
glucose testing cause high levels of distress [3].
More than in any other chronic childhood
disease, children with T1DM have to accept
needles as a part of their daily lives [4].
Most diabetic patients simply accept
injections and blood glucose testing as an
unavoidable part of life. Children or
adolescents with T1DM, who must maintain
desirable glycemic control, may be negatively
bound by the fear of needles and try to avoid
blood sugar monitoring, insulin injections,
and/or CSII site changes [4]. However, for
several others, both newly diagnosed and
those managing the condition over a long
term, the injection process itself can cause
great distress. The striking characteristic of
needle phobia is the evident anxiety at the
very concept of injections or blood glucose
testing, resulting in the attempt to resist them.
Despite the fact that insulin treatment is the
central component of diabetes management for
both type 1 and type 2 diabetes accompanied by
secondary pancreatic insufficiency or
uncontrolled glycemia, poor compliance to
the self-administration of insulin injections
has been noted mostly because of factors like
the fear of insulin or fear of needles [5]. Fear of
needles and its relationship with pain stands
out as one of the most significant factors. This
fear negatively impacts the treatment of
diabetic patients [5].
Intense fear of self-injecting insulin
(injection phobia) remains the most plausible
reason for compromising glycemic control and
precipitating psychological distress [5, 6].
Similarly, the fear of self-monitoring the blood
glucose (SMBG) or pricking the finger can
trigger distress and seriously hamper
self-management. Evidence also suggests that
the fear of blood and injury is linked to less
frequent self-testing and poor glycemic control.
However, there is very limited research work
available on the etiology, prevalence, and
treatment of the fear of self-injecting (FSI) and
fear of self-testing (FST) in patients with type 1
diabetes [7, 8]. The Diabetes Fear of Injecting
and Self-testing Questionnaire (D-FISQ) was
therefore developed as a means of quantifying
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the degree of fear of self-injecting insulin and
self-testing of blood glucose in insulin-treated
diabetic patients [9]. The objective of the
current study was to assess the fear of
self-injecting and self-testing and its associated
risk factors in adolescents with type 1 diabetes
in Saudi Arabia.
METHODS
Study Design, Setting, and Sampling
A cross-sectional type of study was performed
between December 2015 and April 2016,
involving 142 T1DM patients between 13 and
19 years of age, registered in the Diabetes
Treatment Center, Prince Sultan Military Medical
City (PSMMC), Riyadh, Saudi Arabia. Selection of
the respondents was done deliberately and
carefully, and the suitable patients were given
specific identification numbers.
Inclusion and Exclusion Criteria
Patients with T1DM, 13–19 years of age,
undergoing treatment with MDI or insulin
pump (IP) therapy for over 1 year at PSMMC
were selected for the study; those with a history
of psychopathology and cognitive impairment
were excluded. Informed consent, both verbally
and in written form, was obtained from the
patients after clearly explaining the purpose
and research methodology before the
completion of the study measurement.
Diabetes Fear of Injecting and Self-testing
Questionnaire (D-FISQ)
A trained interviewer administered (via
interview) the short version of D-FISQ to each
patient. D-FISQ is a 15-item self-report
questionnaire composed of two subscales that
measure the fear of self-injecting (six-item
subscale) and fear of self-testing (nine-item
subscale), the latter quantifying the fear of
blood glucose testing. A four-point Likert scale
was used to score the items, ranging from one
(almost never) to four (almost always) [6].
Compliance with Ethics Guidelines
This study was conducted in accordance with
the 1975 Declaration of Helsinki, as revised in
2000, and the protocol of this study was
approved by the research ethics committee of
Prince Sultan Military Medical City, Riyadh,
Saudi Arabia.
Statistical Analysis
Data analysis was done with Microsoft Excel
2010, Microsoft Corporation, Seattle, WA, USA
and the Statistical Package for Social Sciences
version 16 SPSS Inc., Chicago, IL, USA. Equal
variances across the groups were performed
employing the Kolmogorov–Smirnov test.
Besides the descriptive analysis, t test and
multiple linear regression analysis were done
to identify the differences among the groups. A
p value of less than 0.05 was accepted as
statistically significant.
RESULTS
Table 1 lists the demographic variables of the
study population. The mean age of the study
cohort was 15.4 ± 2.72 (mean ± SD) years. Of
the 142 patients surveyed, 76 were male (53.5%)
and 66 were female (46.5%). The mean duration
of diagnosis of T1DM was 7.13 ± 4.7
(mean ± SD) and most of the study population
(58.5%) were in the 13- to 16-year age group.
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Variables related to the fear of injection and
self-testing are shown in Table 2. The study
found that the overall mean (SD) score of FSI
was 2.44 ± 0.96, whereas that of FST was
2.25 ± 1.04. On comparison with the 13- to
16-year age group (2.02 ± 1.01), a considerably
higher degree of fear of self-injection of insulin
(2.58 ± 1, p\0.05) was reported among the 17-
to 19-year age group. Compared with the
adolescents who suffered with diabetes for
5 years or less, those who suffered for more
than 5 years revealed a greater degree of fear of
needles in self-testing the blood glucose levels
(p\0.05). Similarly, compared with those using
the IP, adolescents treated with MDI revealed
significantly greater fear of self-injection of
insulin and self-testing of blood glucose
(p\0.05). Fear of self-injection of insulin was
observed to decrease significantly among those
patients with good glycemic control of 7% or
less compared with those having more than 7%.
Identical results were observed for those
adolescents on a daily insulin dose of at most
0.7 units/kg compared with those on a daily
insulin dose of more than 0.07 units/kg.
Interestingly, the fear of insulin injections
dropped among those adolescents who pricked
their fingers four or five times per day compared
with those who pricked themselves only once or
twice daily.
All the statistically significant variables in
the t test were submitted for regression analysis.
Regression analysis indicated that the variables
including older age, MDI treatment, and fewer
finger pricks were independent risk factors for
fear of self-injection of insulin (Table 3),
whereas a fewer number of finger pricks was
an independent risk factor for fear of self-testing
of blood glucose (Table 4).
DISCUSSION
Children with T1DM commonly exhibit fear of
needles [4], which is frequently overlooked. The
current study has shown significant impact of
fear of needles among young patients with type
1 diabetes. Research shows that extreme FSI of
insulin (injection phobia) will probably be
another factor that compromises glycemic
control. The strength of the phobic symptoms
and anxiety-depression can negatively impact
Table 1 Demographic variables of the study population





13–16 years 83 58.5






Duration of diabetes mellitus (years)
B5 years 50 35.2
[5 years 92 64.8
Treatment modality
Multiple daily insulin 103 72.5




Dose of insulin (units per kg)
B0.7 19 13.4
[0.7 123 86.6
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the metabolic control. On the contrary, studies
reported that metabolic control may be
improved by reducing the fear of injection [7].
Further, compared to patients in a Western
setting, the Asian patients with diabetes
revealed a greater degree of fear of injections
and a higher perception of difficulty in using
insulin [5, 10, 11]. The objective of the current
study therefore was to assess the level of fear of
needles and the risk factors related to it among
the Saudi patients with T1DM.
Insulin users consistently indicate several
factors that cause insulin injection-related
anxiety and non-adherence, injection-related
distress continuing to be a significant
contributor. In fact, 57% of American insulin
users reported deliberately avoiding
administering the insulin ‘‘they knew they
should take’’ [12]. Among the newly diagnosed
pediatric patients, 40% reportedly showed
moderate to severe levels of fear for insulin
injection, and the prevalence of fear touched
75% in children younger than 9 years of age
[13]. One research program that studied
children with T1DM between 2 and 21 years of
age (n = 113) showed 27% to be affected by
needle phobia [14]. The current study on
comparing the 13- to 16-year age group
(2.02 ± 1.01) found significantly higher degree
of fear of insulin self-injection (2.58 ± 1,
p\0.05) in the 17- to 19-year age group which
Table 2 Variables associated with diabetes fear of injecting
and self-testing






Male 2.21 ± 1.1 2.33 ± 1.01
Female 2.29 ± 0.991 2.53 ± 0.916
Age (years)
13–16 2.02 ± 1.01 2.31 ± 1.04
17–19 2.58 ± 1* 2.61 ± 0.81
BMI
Underweight 2.18 ± 0.96 2.19 ± 0.84
Normal 2.42 ± 0.98 2.08 ± 0.98
Overweight 2.61 ± 0.87 2.25 ± 1.23
Obese 2.50 ± 1.24 2.54 ± 1.13
Duration of diabetes mellitus (years)
B5 2.04 ± 0.96 2.04 ± 1




2.62 ± 0.96* 2.69 ± 0.99*
Insulin
pump
1.28 ± 0.45 1.77 ± 0.42
HbA1c (%)
B7 1.55 ± 0.555 1.26 ± 0.50
[7 2.76 ± 0.876* 2.62 ± 0.948*
Dose of insulin (units per kg)
B0.7 1.32 ± 0.582 1.53 ± 0.612
[0.7 2.40 ± 1.02* 2.58 ± 0.932*
Average number of ﬁnger pricks per day
1 2.72 ± 1.22 3.11 ± 1.32
2 3.12 ± 0.633* 2.79 ± 0.645*
3 2.12 ± 0.844*# 2.76 ± 0.78*
4 1.52 ± 0.667*#f 1.76 ± 0.614*#f
Table 2 continued





5 1.20 ± 0.414*#f 1.40 ± 0.507*#f
Groups compared by t test and one-way analysis of
variance
Average number of ﬁnger pricks comparisons: * 1 vs 2, 3, 4,
5; # 2 vs 3, 4, 5; f 3 vs 4, 5
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is contrary to the prior finding that young
children rather than the older patients show a
higher degree of fear and report pain with
injections and fingersticks [13]. Compared
with the last decade, although the needles
used today for SMBG are much more fine,
anxieties regarding using needles and fear of
pain may continue to occur, resulting in the
reduced adherence to SMBG [15, 16]. On
comparing patients suffering with diabetes for
at most 5 years with adolescents who suffered
for more than 5 years, this study showed that
the latter revealed greater fear of needles to
self-test the blood glucose.
On comparing the adolescents treatedwith IP
with adolescents treated with MDI, the current
study showed that the latter had significantly
more fear of self-injection of insulin and
self-testing of blood glucose (p\0.05). This
could be because the automatic injection
device, which is a loaded syringe, is put in the
device, locked into place, and automatically
pushed into the skin by a spring-loaded system.
The advantage of this device is that the needle is
not visible and is very quickly jabbed through the
skin [17]. Studies also reveal that compared with
those using the IP, adolescents treated with MDI
show much greater fear of self-injection of
insulin and self-testing of blood glucose, in
particular those on CSII [4, 18]. Further, after
regression analysis, the results of the present
study indicated that MDI treatment was an
independent risk factor for fear of self-injection
of insulin.
Studies reported that adolescents miss or
sometimes even completely cease taking their
Table 3 Results of multiple linear regression analysis (fear of self-injection of insulin)
Variable Fear of self-injection of insulin
b coefﬁcients 95% conﬁdence interval t value p value
Lower Upper
Age 0.348 0.149 0.547 3.46 0.001
Treatment modality -0.667 -0.923 -0.412 -5.17 0.001
Average number of ﬁnger pricks -0.506 -0.609 -0.402 -9.67 0.001
Hemoglobin A1c (%) 0.213 -0.083 0.508 1.42 0.157
Dose of insulin (units/kg) -0.220 -0.554 0.115 -1.30 0.197
Table 4 Results of multiple linear regression analysis (fear of self-testing of blood glucose)
Variable Fear of self-testing of blood glucose
b coefﬁcients 95% conﬁdence interval t value p value
Lower Upper
Diabetes duration 0.197 -0.028 0.421 1.7 0.85
Treatment modality -0.155 -0.429 0.118 -1.1 0.263
Average number of ﬁnger pricks -0.507 -0.621 -0.393 -8.8 0.00
Hemoglobin A1c (%) 0.224 -0.093 0.540 1.4 0.164
Dose of insulin (units/kg) 1.13 -0.361 0.360 -231 0.998
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insulin injections because of fear of needles,
which is confirmed by the present findings
[15, 16]. A similar observation was noted in a
study performed in Saudi Arabia in which 79%
of the patients were non-compliant with their
insulin regimen [19]. A low degree of
compliance was seen in commencing and
continuing with their needle-based therapies
like insulin administration [7]. Fear of
self-injection of insulin was found to
considerably drop among patients with A1c
values below 7%, which is confirmed by the
present study [7].
Patients who control their glycemic level at
7% or less were seen to express a lesser degree of
fear of self-injection of insulin and self-testing
of blood glucose compared with those with
HbA1c values higher than 7%. Research has
revealed that insulin administration is
frequently needed in diabetes mellitus
management to maintain optimal glycemic
control. In spite of this, however, several
patients hesitate to begin insulin treatment
[4]. In the general population, several factors
leading to this reluctance have been identified,
one of the most frequent being the fear of
needles. Such barriers are also evident in
multi-ethnic populations. One study recently
reported that patients with a higher degree of
fear of needles reveal higher HbA1c levels and
more infrequent blood sugar monitoring [4]. In
another study, patients having positive scores
for fear of injections reportedly showed
significantly higher HbA1c levels than those
lacking this fear [20].
In the current study, regression analysis
showed that a fewer number of finger pricks
was a negative independent risk factor for
self-testing of blood glucose. Children with
type 1 diabetes generally begin with two
insulin injections per day using two different
types of insulin and normally continue on to
three or four insulin injections per day using
different types of insulin [21]. The types of
insulin used varied with the levels of blood
glucose. According to some research three or
four insulin injections per day provides the best
blood glucose control and can avert or defer
diabetes-induced microvascular complications.
In many instances, however, children would
avoid injecting the insulin injection out of fear
of needles [22, 23]. In this study, an interesting
fact discovered was that the fear of insulin
injection and fear of self-testing of blood
glucose were less among those adolescents
who pricked four to five times per day
compared with those who pricked only once
or twice a day. This implies that a regular habit
of injection may reduce the fear of needles.
Research has revealed that SMBG is effective in
enhancing the degree of self-care in patients
with diabetes. SMBG heightens the
empowerment of patients with diabetes,
helping them to accurately estimate the effects
of alterations in lifestyle and medications on
their blood glucose levels. However, some
research showed that fingertip pricking was
painful for certain patients, who therefore
avoided practicing SMBG quite often, even in
developed countries. In the USA and Italy, only
a limited minority of patients with diabetes and
injecting insulin practiced at least daily SMBG
(26% and 13.9%, respectively), despite the
monitoring devices being provided at no cost
in Italy [24, 25]. The studies also reported that
this could be a result of older age, lower levels of
diabetes education, lesser comorbidities, fear of
testing and pain [26].
The major limitations of this study include
its cross-sectional nature, the small sample size,
and the fact that it was performed at a single
center. More studies on a larger scale are needed
to address the limitations indicated in the
study. Despite the limitations, the study
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delivers valuable data about the insulin pump
treatment and satisfaction among adolescents
with T1DM.
CONCLUSION
It is quite common among children with T1DM
to have a fear of needles. However, although
this is frequently missed, the current study has
revealed the remarkable impact the fear of
needles exerts on type 1 diabetes. This study
identified some significant risk factors for fear of
needles: age, duration of diabetes and treatment
modality, besides glycemic control, insulin
dosage, and number of finger pricks on
average. Although the needles used today for
SMBG and insulin injections are much finer
than those of earlier times, the fear of using
needles and pain may continue to be
encountered and thus lead to a lower
compliance with SMBG and self-injection of
insulin. Healthcare providers, diabetes
educators in particular, need to carefully
consider these factors when discussing SMBG
with children diagnosed with diabetes and their
caregivers. The diabetes educationist should be
trained to employ techniques to reduce the pain
during finger prick, for example, by pricking the
lateral aspect of the finger, avoiding pricking
the thumbs and index fingers, or pricking to
shallower needle depths; besides, they could be
advised to utilize alternative testing sites, like
the arm, abdomen, and thigh to rest the fingers
for some length of time.
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